Issues

Effekte von Teriparatid auf knochenhistologische Parameter bei einer Patientin mit adynamer renaler Knochenerkrankung und Wirbelkörperfrakturen

Journal: Osteologie
ISSN: 1019-1291
Topic:

Kalzium-Phosphat-Stoffwechsel und Knochen

Issue: Issues of 2017 (Vol. 26): HeIssue 3 2017 (131-191)
Pages: 153-156

  1. Cournot-Witmer G, Zingraff J, Plachot JJ et al. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney international 1981; 20 (3): 375-378. DOI:10.1038/ki.1981.149
  2. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. American journal of kidney diseases : the official journal of the National Kidney Foundation 2000; 36 (6): 1115-1121. DOI:10.1053/ajkd.2000.19812
  3. London GM, Marty C, Marchais SJ et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. Journal of the American Society of Nephrology 2004; 15 (7): 1943-1951. DOI:10.1097/01.ASN.0000129337.50739.48
  4. Morley P, Whitfield JF, Willick GE. Parathyroid hormone: an anabolic treatment for osteoporosis. Current pharmaceutical design 2001; 7 (8): 671-687. DOI:10.2174/1381612013397780
  5. Fu Q, Jilka RL, Manolagas SC, O‘Brien CA. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. The Journal of biological chemistry 2002; 277 (50): 48868-48875. DOI:10.1074/jbc.M208494200
  6. Lee SK, Lorenzo JA. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Bone 2002; 31 (1): 252-259. DOI:10.1016/S8756-3282(02)00804-9
  7. Lehmann G, Ott U, Maiwald J, Wolf G. Bone histomorphometry after treatment with teriparatide (PTH 1-34) in a patient with adynamic bone disease subsequent to parathyroidectomy. NDT plus 2009; 2 (1): 49-51.
  8. Trueba D, Sawaya BP, Mawad H, Malluche HH. Bone biopsy: indications, techniques, and complications. Seminars in dialysis 2003; 16 (4): 341-345. DOI:10.1046/j.1525-139X.2003.160631.x
  9. Merz WA, Schenk RK. Quantitative structural analysis of human cancellous bone. Acta anatomica. 1970; 75 (1): 54-66. DOI:10.1159/000143440
  10. Parfitt AM, Drezner MK, Glorieux FH et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. Journal of bone and mineral research 1987; 2 (6): 595-610. DOI:10.1002/jbmr.5650020617
  11. Dempster DW, Cosman F, Kurland ES et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. Journal of bone and mineral research 2001; 16 (10): 1846-1853. DOI:10.1359/jbmr.2001.16.10.1846
  12. Compston JE. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure. Bone 2007; 40 (6): 1447-1452. DOI:10.1016/j.bone.2006.09.008
  13. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. The New England journal of medicine 2001; 344 (19): 1434-1441. DOI:10.1056/NEJM200105103441904

You may also be interested in...

1.
S. Scharla

Die Medizinische Welt 2004 55 1: 5-

2.

C. Biehl (1), F. Merboth (2), T. ElKassawna (2), M. Rupp (1), C. Heiß (1, 2)

arthritis + rheuma 2017 37 4: 239-246

3.

A. vom Scheidt (1), B. Busse (1)

Osteologie 2016 25 2: 69-76